Stem Cell Research & Therapy,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Dec. 18, 2024
Periodontal
ligament
stem
cell
(PDLSC)-based
therapy
is
one
of
the
methods
to
assist
bone
regeneration.
Understanding
functional
regulation
PDLSCs
and
mechanisms
involved
a
crucial
issue
in
This
study
aimed
explore
roles
family
with
sequence
similarity
96
member
B
(FAM96B)
PDLSCs.
To
assess
osteogenic
differentiation
PDLSCs,
alkaline
phosphatase
(ALP)
activity
assay,
Alizarin
red
staining,
quantitative
calcium
analysis,
marker
detection
were
conducted.
Transplantation
under
dorsum
nude
mice
into
rat
calvarial
defects
also
performed.
Then,
FAM96B-overexpressed
used
for
RNA-sequencing
bioinformatic
analysis.
evaluate
ferroptosis
cytosolic
reactive
oxygen
species
(ROS),
expression
glutathione
peroxidase
4
(GPX4),
mitochondrial
morphology
functions
including
ROS,
mitochondria
membrane
potential,
respiration
detected.
The
indicators
ALP
activity,
level
mineralization,
osteocalcin
decreased
by
FAM96B,
which
demonstrated
that
FAM96B
inhibited
knockdown
promoted
new
formation
subcutaneously
transplanted
mice.
related
biological
detected
was
focused.
enhanced
ROS
GPX4
Hence,
Meanwhile,
we
found
inhibition
upregulated
target
gene
FOS
like
1,
AP-1
transcription
factor
subunit
(FOSL1)
FOSL1
vitro.
defects.
inhibitory
effect
on
confirmed.
depletion
suppressed
negatively
regulated
downstream
via
ferroptosis.
our
findings
provided
foundation
understanding
FAM96B-FOSL1
axis
acting
as
MSC
mediated
Human Molecular Genetics,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 29, 2025
Abstract
Activation
of
bone
morphogenetic
protein
(BMP)
4
signaling
promotes
the
survival
retinal
ganglion
cell
(RGC)
after
acute
injury.
In
this
study,
we
investigated
role
BMP4
pathway
in
regulating
degeneration
cells
(RGCs)
a
mouse
glaucoma
model
and
its
potential
application
stem
cell.
Our
results
demonstrate
that
BMP4-GPX4
not
only
reduces
oxidative
stress
iron
accumulation
but
also
neuroprotective
factors
support
transplanted
RSCs
into
host
retina.
These
findings
suggest
novel
therapeutic
approach
for
involving
modulation
to
protect
RGCs
improve
visual
function
through
enhanced
RSC
differentiation.
BMC Gastroenterology,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: Jan. 30, 2025
Colorectal
cancer
(CRC)
is
one
common
tumor
with
the
high
death
rate,
and
badly
affects
normal
lives
of
CRC
patients.
Amarogentin
(AG)
has
been
found
to
exhibit
regulatory
roles
join
into
progression
multiple
diseases.
However,
impacts
associated
molecular
mechanisms
AG
in
keep
unclear.
In
this
study,
it
was
demonstrated
that
weakened
cell
viability
a
concentration-
time-dependent
manner.
addition,
accelerated
apoptosis
by
triggering
ferroptosis.
The
invasion
EMT
process
were
restrained
after
treatment,
but
these
reversed
Fer-1
addition.
Moreover,
uncovered
retarded
Nrf2/HO-1/GPX4
activation.
Additionally,
modulated
PTC
stimulated
At
last,
illustrated
suppressed
growth
vivo.
conclusion,
disclosed
proliferation
through
inducing
ferroptosis
CRC,
This
discovery
suggested
may
be
effective
drug
for
ameliorating
progression.
Stem Cell Research & Therapy,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Feb. 4, 2025
Abstract
Type
1
diabetes
mellitus
(T1DM)
is
characterized
by
progressive
β-cell
death,
leading
to
loss
and
insufficient
insulin
secretion.
Mesenchymal
stem
cells
(MSCs)
transplantation
currently
one
of
the
most
promising
methods
for
replacement
therapy.
However,
recent
studies
have
shown
that
ferroptosis
not
only
key
mechanisms
but
also
reasons
extensive
cell
death
within
a
short
period
time
after
MSCs
transplantation.
Ferroptosis
new
type
regulated
(RCD)
iron-dependent
accumulation
lipid
peroxides.
Due
weak
antioxidant
capacity
β-cells,
they
are
susceptible
cytotoxic
stimuli
such
as
oxidative
stress
(OS),
therefore
ferroptosis.
Transplanted
extremely
perturbations
in
their
microenvironment,
especially
OS,
which
can
weaken
induce
through
In
pathophysiological
process
T1DM,
large
amount
reactive
oxygen
species
(ROS)
produced,
causing
OS.
Therefore,
targeting
may
be
way
protect
β-cells
improve
therapeutic
effect
This
review
reviews
research
related
MSCs,
summarizes
developed
strategies
help
inhibit
study
aims
understand
mechanism
transplantation,
emphasize
importance
protecting
improving
survival
function
transplanted
provide
direction
therapy
T1DM
future.
Antioxidants,
Journal Year:
2025,
Volume and Issue:
14(2), P. 189 - 189
Published: Feb. 6, 2025
Current
research
suggests
that
promoting
ferroptosis,
a
non-apoptotic
form
of
cell
death,
may
be
an
effective
therapy
for
osteosarcoma,
while
its
inhibition
could
facilitate
bone
regeneration
and
prevent
osteoporosis.
Our
objective
was
to
investigate
whether
the
susceptibility
regulation
ferroptosis
differ
between
undifferentiated
(UBC)
differentiated
(DBC)
human
marrow
stromal
cells,
as
well
osteosarcoma
cells
(MG63).
Ferroptosis
induced
by
either
inhibiting
glutathione
peroxidase
4
(GPX4)
using
RSL3
or
blocking
all
glutathione-dependent
enzymes
through
glutamate/cysteine
antiporter
with
Erastin.
Lipid
peroxidation
assessed
fluorescent
probe
BODIPY™581/591C11,
Ferrostatin-1
used
inhibit
ferroptosis.
We
demonstrate
neither
Erastin
nor
induces
in
DBC.
However,
both
induce
UBC,
predominantly
MG63
cells.
data
suggest
induction
hBMSCs
is
primarily
regulated
GPX4,
whereas
S-Transferase
P1
(GSTP1)
plays
key
role
controlling
In
conclusion,
targeting
pathways
involved
across
different
types
improve
efficacy
cancer
treatments
minimizing
collateral
damage
supporting
regenerative
processes,
minimal
impact
on
therapy.
Inflammation,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 22, 2025
Bone
marrow
mesenchymal
stem
cells
(BMSCs)
play
an
important
role
in
bone
metabolism
and
tissue
repair,
their
ability
to
differentiate
into
osteoblasts
is
crucial
the
treatment
of
diseases
such
as
postmenopausal
osteoporosis
(PMOP).
However,
function
BMSCs
may
be
affected
by
ferroptosis.
Ferroptosis
a
cell
death
mode
characterized
excess
Fe2+
lipid
peroxidation,
which
significantly
affects
survival
rate
differentiation
BMSCs.
This
study
investigated
effect
exogenous
itaconate
derivative
4-octyl
(4-OI)
on
Erastin-induced
The
results
showed
that
4-OI
inhibited
ferroptosis
activating
nuclear
factor
erythroid
2-related
2
(Nrf2)
signaling
pathway,
reduced
reactive
oxygen
species
levels
oxidative
damage,
restored
antioxidant
capacity.
At
same
time,
promoted
osteogenic
Further
experiments
Nrf2-IN-1,
inhibitor
Nrf2
could
reverse
protective
4-OI.
In
vivo,
was
shown
reduce
loss
ovariectomized
(OVX)
mice,
assessed
Micro-CT
analysis.
Immunofluorescence
staining
further
revealed
increased
GPX4
expression
vertebral
tissues
following
treatment.
These
indicate
improves
enhances
providing
new
research
ideas
potential
targets
for
PMOP.
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 31, 2025
Abstract
Spinal
cord
injury
(SCI)
is
one
of
the
most
devastating
and
catastrophic
types
injury,
with
high
rates
mortality
disability.
Ferroptosis
has
become
target
many
major
incurable
human
diseases.
By
inhibiting
ferroptosis,
melatonin
(MT)
can
reduce
damage
in
various
organs,
but
protective
effect
MT
on
SCI
not
been
reported
yet.
The
modified
Ellen's
method
was
used
to
establish
an
rat
model.
spinal
neurons
recovery
motor
function
were
observed.
In
vitro
experiments,
oxygen-glucose
deprivation/reoxygenation
(OGD/R)
model
established
by
using
mouse
hippocampal
neuron
(HT22)
cells
simulate
ischemia-reperfusion
injury.
A
ferroptosis
directly
induced
Erastin
also
used.
nuclear
factor
erythroid
2-related
2
(Nrf2)
inhibitor
ML
385
further
detect
mechanism
through
which
inhibits
protects
neuronal
cells.
Our
study
demonstrates
that
rats,
promote
behavior
injured
tissue
after
SCI.
Under
electron
microscope,
inhibited
rescued
damaged
mitochondria,
partially
restored
mitochondrial
structure.
ML385,
Nrf2
inhibitor,
reversed
effects
MT.
Overall,
may
alleviate
early
activating
Nrf2/heme
oxygenase-1(HO-1)/glutathione
peroxidase
4
(GPX
4)
pathway.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 6, 2024
As
a
mechanism
of
cell
death,
ferroptosis
has
gained
popularity
since
2012.
The
process
is
distinguished
by
iron
toxicity
and
phospholipid
accumulation,
in
contrast
to
autophagy,
apoptosis,
other
death
mechanisms.
It
implicated
the
advancement
multiple
diseases
across
body.
Researchers
currently
know
that
osteosarcoma,
osteoporosis,
orthopedic
disorders
are
caused
NRF2,
GPX4,
star
proteins.
effective
relief
osteoarthritis
symptoms
from
deterioration
been
confirmed
clinical
treatment
with
inhibitors.
At
same
time,
it
should
be
reminded
mechanisms
involved
regulate
not
understood.
In
this
manuscript,
we
present
discovery
ferroptosis,
role
variety
diseases.
We
expect
manuscript
can
provide
new
perspective
on
diagnosis
related
Phytotherapy Research,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 8, 2024
Degenerative
bone
and
joint
diseases
(DBJDs),
characterized
by
osteoporosis,
osteoarthritis,
chronic
inflammation
of
surrounding
soft
tissues,
are
systemic
conditions
primarily
affecting
the
skeletal
system.
Ferroptosis,
a
programmed
cell
death
pathway
distinct
from
apoptosis,
autophagy,
necroptosis.
Accumulating
evidence
suggests
that
ferroptosis
is
intricately
linked
to
pathogenesis
DBJDs,
targeting
its
regulation
could
be
beneficial
in
managing
these
conditions.
Natural
products,
known
for
their
anti-inflammatory
antioxidant
properties,
have
shown
unique
advantages
preventing
potentially
through
modulating
ferroptosis.
This
article
provides
an
overview
latest
research
on
ferroptosis,
with
focus
role
DBJDs
therapeutic
potential
natural
products
this
pathway,
offering
novel
insights
prevention
treatment
DBJDs.